| Title : Treatment with the selective muscarinic agonist talsaclidine decreases cerebrospinal fluid levels of total amyloid beta-peptide in patients with Alzheimer's disease - Hock_2000_Ann.N.Y.Acad.Sci_920_285 |
| Author(s) : Hock C , Maddalena A , Heuser I , Naber D , Oertel W , von der Kammer H , Wienrich M , Raschig A , Deng M , Growdon JH , Nitsch RM |
| Ref : Annals of the New York Academy of Sciences , 920 :285 , 2000 |
| Abstract : Hock_2000_Ann.N.Y.Acad.Sci_920_285 |
| ESTHER : Hock_2000_Ann.N.Y.Acad.Sci_920_285 |
| PubMedSearch : Hock_2000_Ann.N.Y.Acad.Sci_920_285 |
| PubMedID: 11193166 |
Hock C, Maddalena A, Heuser I, Naber D, Oertel W, von der Kammer H, Wienrich M, Raschig A, Deng M, Growdon JH, Nitsch RM (2000)
Treatment with the selective muscarinic agonist talsaclidine decreases cerebrospinal fluid levels of total amyloid beta-peptide in patients with Alzheimer's disease
Annals of the New York Academy of Sciences
920 :285
Hock C, Maddalena A, Heuser I, Naber D, Oertel W, von der Kammer H, Wienrich M, Raschig A, Deng M, Growdon JH, Nitsch RM (2000)
Annals of the New York Academy of Sciences
920 :285